Search over 3,000 reports

    Esbriet- Drug Insight, 2017

    Esbriet- Drug Insight, 2017
    Date: Jan, 2018
    Type: Pharmaceutical Industry Report
    Pages: 35
    Geography: Global
    Delivery Timeline: 48 hours
    SKU: DIDI0122
    "Esbriet - Drug Insight, 2018" report by DelveInsight provides comprehensive information of the drug, Esbriet. It includes Esbriet`s overview, mechanism, clinical trials, regulatory milestones, deals & partnerships. It further provides Esbriet`s patents (US & EU)* and its API manufacturers details in the United States, Europe, China and India.* It also features the historical and forecasted sales of Esbriet till 2020. The report also throws light on Esbriet`s market competition and emerging therapies in the same space as Esbriet. A SWOT analysis of Esbriet is also featured.
    * Depending on information availability

    Methodology
    Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight’s team of industry experts.
    Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

    Scope of the report
    • A comprehensive product overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report
    • Patent information around Esbriet in United States (US) and Europe (EU) has been highlighted
    • API manufacturers for Esbriet in United States, Europe, China and India
    • The report contains historical and forecasted sales for Esbriet till 2020
    • Comprehensive coverage of the emerging therapies (Phase III) in the space where Esbriet operates including their product description, research and development activities, collaborations and licensing deals, drug mechanism and chemical information
    • The report also features the SWOT analysis of Esbriet

    Reasons to Buy
    • Establish a comprehensive understanding of the drug, Esbriet
    • Access to Esbriet`s API manufacturers details to devise API procurement strategy for generic development
    • Plan developmental timelines around Esbriet`s patents for the major markets- US and EU
    • Understand Esbriet`s current and future growth through its historical and forecasted sales
    • Identify and understand the current in-market competitors for Esbriet
    • Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
    • Identify and plan ahead for prospective emerging players and their products operating in the same space as Esbriet
    • Identify opportunities in the same area as Esbriet with DelveInsight`s SWOT analysis
    1. Report Introduction
    2. Esbriet - Overview
    • Product Description
    • Route of Synthesis
    • Mechanism of Action
    • Pharmacology
    • Pharmacodynamics
    • Pharmacokinetics
    • Adverse Reactions
    • Clinical Trials
    • Regulatory Milestones
    • Product Development Activities
    3. Global API Manufacturers
    • United States
    • Europe
    • China
    • India
    4. Product Details
    • United States
    • Europe
    5. Esbriet Global Sales Assessment
    • Historical Global Sales
    • Forecasted Global Sales
    6. Patent Details
    7. Market Competition
    8. Emerging Therapies
    8.1. Drug name: Company name
    • Product Description
    • Research & Development
    • Product Development Activities
    Other product profiles in the detailed report…..
    9. SWOT Analysis
    Appendix
    Methodology
    Consulting Services
    About DelveInsight
    Contact Us
    Disclaimer
    Note: Certain sections of the table of contents would vary according to the availability of information
    Table 1: Esbriet, Description
    Table 2: API Manufacturers Region wise
    Table 3: API Manufacturers for United States
    Table 4: API Manufacturers for Europe
    Table 5: API Manufacturers for China
    Table 6: API Manufacturers for India
    Table 7: Esbriet Product Details, United States
    Table 8: Esbriet Product Details, Europe
    Table 9: Esbriet, Historical Global Sales till 2017 (in million USD)
    Table 10: Esbriet, Forecasted Global Sales from 2018-2020 (in million USD)
    Table 11: Patent Details: Esbriet
    Table 12: Esbriet Major Competitors
    Table 13: Emerging Therapies
    Figure 1: Esbriet
    Figure 2: Esbriet, Historical Global Sales till 2017 (in million USD)
    Figure 3: Esbriet, Forecasted Global Sales from 2018-2020 (in million USD)
    Figure 4: Patent Details: Esbriet
    Figure 5: API Manufacturers Region wise
    Esbriet

    Esbriet Marketed Drugs Overview

    Esbriet Market Assessment

    Esbriet API Manufacturers/ Active Pharmaceutical Ingredients Manufacturers

    Esbriet US DMF

    Esbriet US Drug Master Files

    Esbriet Active Substance Master File/ EUDMF

    Esbriet Generic players

    Esbriet Patent Expiration

    Esbriet Patent Exclusivity

    Esbriet API Manufacturers

    Esbriet Global Forecasted Sales Figure

    Esbriet API Route of Synthesis

    Esbriet Market sales

    Esbriet SWOT Analysis

    Esbriet Pipeline

    • Single User License
      (20% Off)
      $1,000.00
    • Site License
      (30% Off)
      $2,000.00
    • Global License
      (40% Off)
      $3,000.00

    Contact Us

    Phone
    +91-11-45689769, +91 9650213330

    Email
    info@delveinsight.com

    Address
    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap